Autopsy Gets Virtual
Sign in

editricon Autopsy gets Virtual

Managing Editor
Technology is revolutionizing in every field. In the past, we have heard about interesting technologies in healthcare sector, where in a doctor, who sits at U.S can do a surgery for a patient in India. But, when I heard about a technology developed by a company to do the autopsy (postmortem) similarly, it sounded weird to me. Can you imagine a dead body, without even having a pinpoint mark in the body; an autopsy process can be completed? But Suresh Chandran, COO of iGene is betting through iGene’s autopsy solution to prove that it is possible.

It’s interesting, when I explored more about the company. iGene based in Kaula Lampur, is the only company that has developed an autopsy solutions. Suresh Chandran saw a dearth in the utilization of technology in the health care sector and he eyed an opportunity in healthcare sector. iGene have developed a term called digital autopsy where in how to develop a high performance computing environment in a high definition visualization kind of technology to reconstruct a virtual body.

When a body reaches a morgue, the body is passed through a standard CD scanner. Once the scanning process is done, the data generated by the scanner is captured. By rendering the data, a full 3D body is created virtually. The pathologist in his visualization room can access this virtual body, where in he can sit comfortably in his own room with visualization panel and he can view all these 3D bodies. iGene develops preset set of tools and navigational tools, so that the doctors can do the postmortem using these tools. The entire autopsy process can be completed within 35 to 40 minutes. While the pathologist is doing the autopsy digitally, he can go either by geographical region or layer by layer, and still the original body is not affected. The company is working with many hospitals, educational institutions in North America, Latin America, European groups, and Carribean Group. As the company is planning to go international, iGene is scouting for funding right now. Suresh thinks that, for any company timing is very important to position itself in the market. I hope this Indian will be keen in making this technology available in India as soon as possible.

start_blog_img